1. Rossi, M. et al. Autosomal dominant cerebellar ataxias: a systematic review of clinical features. Eur. J. Neurol. 21, 607–615 (2014).
2. Amberger, J. S., Bocchini, C. A., Schiettecatte, F., Scott, A. F. & Hamosh, A. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 43, D789–D798 (2015).
3. Landrum, M. J. et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 44, D862-868 (2016).
4. Köhler, S. et al. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Res. 47, D1018–D1027 (2019).
5. Ngo, K. J. et al. A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders. Hum. Mutat. 41, 487–501 (2020).
6. Yahia, A. & Stevanin, G. The History of Gene Hunting in Hereditary Spinocerebellar Degeneration: Lessons From the Past and Future Perspectives. Front. Genet. 12, (2021).
7. Sun, Y. et al. Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease). Hum. Mutat. 34, 706–713 (2013).
8. Coutelier, M. et al. Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes. JAMA Neurol. 75, 591–599 (2018).
9. Shakya, S. et al. Whole exome and targeted gene sequencing to detect pathogenic recessive variants in early onset cerebellar ataxia. Clin. Genet. 96, 566–574 (2019).
10. Faruq, M. et al. Novel mutations in typical and atypical genetic loci through exome sequencing in autosomal recessive cerebellar ataxia families. Clin. Genet. 86, 335–341 (2014).
11. Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. Off. J. Am. Coll. Med. Genet. 17, 405–424 (2015).
12. Kopanos, C. et al. VarSome: the human genomic variant search engine. Bioinformatics 35, 1978–1980 (2019).
13. Li, Q. & Wang, K. InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am. J. Hum. Genet. 100, 267–280 (2017).
14. Hekman, K. E. et al. A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult. Hum. Mol. Genet. 21, 5472–5483 (2012).
15. Hizli, A. A. et al. Phosphorylation of Eukaryotic Elongation Factor 2 (eEF2) by Cyclin A–Cyclin-Dependent Kinase 2 Regulates Its Inhibition by eEF2 Kinase. Mol. Cell. Biol. 33, 596–604 (2013).
16. Nibbeling, E. A. R. et al. Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia. Brain J. Neurol. 140, 2860–2878 (2017).
17. Calvo, S. E. et al. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci. Transl. Med. 4, 118ra10 (2012).
18. Di Gregorio, E. et al. ELOVL5 mutations cause spinocerebellar ataxia 38. Am. J. Hum. Genet. 95, 209–217 (2014).
19. Lambe, J., Monaghan, B., Munteanu, T. & Redmond, J. CAPN1 mutations broadening the hereditary spastic paraplegia/spinocerebellar ataxia phenotype. Pract. Neurol. 18, 369–372 (2018).
20. Fogel, B. L. et al. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol. 71, 1237–1246 (2014).
21. Rossi, M. et al. The genetic nomenclature of recessive cerebellar ataxias. Mov. Disord. Off. J. Mov. Disord. Soc. 33, 1056–1076 (2018).
22. Coppieters, F., Lefever, S., Leroy, B. P. & De Baere, E. CEP290, a gene with many faces: mutation overview and presentation of CEP290base. Hum. Mutat. 31, 1097–1108 (2010).
23. Hong, S. E. et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat. Genet. 26, 93–96 (2000).
24. Ns, R. et al. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer’s disease: a case series. The Lancet. Neurology https://pubmed.ncbi.nlm.nih.gov/27777022/ (2016).
25. Y, S., I, K. & S, I. Spinocerebellar Ataxia-Like Presentation of the M233V PSEN1 Mutation. Cerebellum (London, England) https://pubmed.ncbi.nlm.nih.gov/32594361/ (2020).
26. Becker, P. S., Tse, W. T., Lux, S. E. & Forget, B. G. Beta spectrin kissimmee: a spectrin variant associated with autosomal dominant hereditary spherocytosis and defective binding to protein 4.1. J. Clin. Invest. 92, 612–616 (1993).
27. McCann, S. R. & Jacob, H. S. Spinal cord disease in hereditary spherocytosis: report of two cases with a hypothesized common mechanism for neurologic and red cell abnormalities. Blood 48, 259–263 (1976).
28. Lim, E. T. et al. Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder. Nat. Neurosci. 20, 1217–1224 (2017).
29. Takata, A. et al. Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder. Cell Rep. 22, 734–747 (2018).
30. Steinberg, K. M., Yu, B., Koboldt, D. C., Mardis, E. R. & Pamphlett, R. Exome sequencing of case-unaffected-parents trios reveals recessive and de novo genetic variants in sporadic ALS. Sci. Rep. 5, 9124 (2015).
31. Gan-Or, Z. et al. Mutations in CAPN1 Cause Autosomal-Recessive Hereditary Spastic Paraplegia. Am. J. Hum. Genet. 98, 1038–1046 (2016).
32. Depondt, C. et al. MME mutation in dominant spinocerebellar ataxia with neuropathy (SCA43). Neurol. Genet. 2, (2016).
33. Sorimachi, H. et al. A novel member of the calcium-dependent cysteine protease family. Biol. Chem. Hoppe. Seyler 371 Suppl, 171–176 (1990).
34. Hsu, C.-Y. et al. Deimination of human filaggrin-2 promotes its proteolysis by calpain 1. J. Biol. Chem. 286, 23222–23233 (2011).
35. Angst, B. D., Marcozzi, C. & Magee, A. I. The cadherin superfamily: diversity in form and function. J. Cell Sci. 114, 629–641 (2001).
36. Matsui, S. et al. Knockdown of Fat2 by siRNA inhibits the migration of human squamous carcinoma cells. J. Dermatol. Sci. 51, 207–210 (2008).
37. Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. bioRxiv 531210 (2020) doi:10.1101/531210.
38. Bezprozvanny, I. Calcium signaling and neurodegenerative diseases. Trends Mol. Med. 15, 89–100 (2009).
39. Kasumu, A. & Bezprozvanny, I. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias. Cerebellum Lond. Engl. 11, 630–639 (2012).
40. Chen, X. et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3. J. Neurosci. Off. J. Soc. Neurosci. 28, 12713–12724 (2008).
41. Malchiodi-Albedi, F., Ceccarini, M., Winkelmann, J. C., Morrow, J. S. & Petrucci, T. C. The 270 kDa splice variant of erythrocyte beta-spectrin (beta I sigma 2) segregates in vivo and in vitro to specific domains of cerebellar neurons. J. Cell Sci. 106, 67–78 (1993).
42. Lise, S. et al. Recessive mutations in SPTBN2 implicate β-III spectrin in both cognitive and motor development. PLoS Genet. 8, e1003074 (2012).
43. Puchkov, D., Leshchyns’ka, I., Nikonenko, A. G., Schachner, M. & Sytnyk, V. NCAM/Spectrin Complex Disassembly Results in PSD Perforation and Postsynaptic Endocytic Zone Formation. Cereb. Cortex 21, 2217–2232 (2011).
44. Nestor, M. W., Cai, X., Stone, M. R., Bloch, R. J. & Thompson, S. M. The Actin Binding Domain of βI-Spectrin Regulates the Morphological and Functional Dynamics of Dendritic Spines. PLoS ONE 6, (2011).
45. Ikeda, H. et al. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat. Genet. 13, 196–202 (1996).
46. Saitsu, H. et al. Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay. Am. J. Hum. Genet. 86, 881–891 (2010).
47. Knierim, E. et al. A recessive mutation in beta-IV-spectrin (SPTBN4) associates with congenital myopathy, neuropathy, and central deafness. Hum. Genet. 136, 903–910 (2017).
48. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinforma. Oxf. Engl. 30, 2114–2120 (2014).
49. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
50. Stenson, P. D. et al. The Human Gene Mutation Database: 2008 update. Genome Med. 1, 13 (2009).
51. 1000 Genomes Project Consortium et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
52. Zhang, Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9, 40 (2008).
53. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1–2, 19–25 (2015).
54. Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785–2791 (2009).
55. Kumar, D. et al. Generation of three spinocerebellar ataxia type-12 patients derived induced pluripotent stem cell lines (IGIBi002-A, IGIBi003-A and IGIBi004-A). Stem Cell Res. 31, 216–221 (2018).